B+
Bull case
0%
Probability
Target price
$137.00
Analysis reference price unavailable
Analysis 2026-09-30 · RankAlpha Sentiment Codex
BCO
Brink'sCNYSE / Commercial & Professional Services
Last Price
Quote time unavailable
Current thesis
Q2 revenue rose 7%, adjusted EBITDA 11% and non-GAAP EPS 18% year over year; AMS/DRS growth and productivity support margins and cash generation. An acceptable UK remedy could restore confidence in the acquisition and its planned synergies.
Posture
Mixed
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.1.
What can break
Currency volatility, Argentina conditions and deployment timing could pressure revenue or margins; the company introduced quarterly guidance partly to clarify near-term currency and economic effects. company Q2 release
Momentum
34
Value
65
Sentiment
47
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $105.00 · Bull $137.00 · Bear $70.00Analysis 2026-09-30; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-09-30 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-23
Investment thesis
As of 2026-10-23
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $146.33
Why
Momentum34 · Δ7d -0.2
Value65 · Δ7d -0.1
Sentiment47 · Δ7d -5.1
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta -0.1.
Contradictions & invalidation
- • Currency volatility, Argentina conditions and deployment timing could pressure revenue or margins; the company introduced quarterly guidance partly to clarify near-term currency and economic effects. company Q2 release
- • Remedies could reduce deal economics; financing, integration and realization of the planned $200 million run-rate synergies remain uncertain. [#SEC-8K-2026-08-05]
- • The CMA's September 30 finding creates a concrete risk of phase 2 review, remedy costs or a delayed closing.
Catalyst clock
2026-09-30
UK merger review turns adverse
Lead driver: Value · See fundamentals
Momentum
34
8% active weight
Current posture
7d trendSoftening
Δ7d
-0.2
Δ21d
-10.4
Value
65
47% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
-0.3
Sentiment
47
45% active weight
Current posture
7d trendSoftening
Δ7d
-5.1
Δ21d
-18.3
Why this grade
Composite grade C. Momentum 34.0 / Value 65.0 / Sentiment 46.9
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-09-30. Scenario method
Most likely
B
Base case
0%
Probability
Target price
$105.00
Analysis reference price unavailable
Analysis 2026-09-30 · RankAlpha Sentiment Codex
B-
Bear case
0%
Probability
Target price
$70.00
Analysis reference price unavailable
Analysis 2026-09-30 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-23
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$4.58B
Beta
1.09
Shares Out
41.19M
P/E (TTM)
30.5
P/S (TTM)
0.97
P/FCF (TTM)
13.26
Rev YoY
+7.1%
EPS YoY
+3.8%
Gross Margin
+26.4%
Op Margin
+10.4%
Net Debt
$2.35B
Current Ratio
1.62
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data